The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is UnitedHealth Group (UNH - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
UnitedHealth Group is a member of the Medical sector. This group includes 841 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. UNH is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for UNH's full-year earnings has moved 0.79% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that UNH has returned about 22.10% since the start of the calendar year. Meanwhile, the Medical sector has returned an average of 1.12% on a year-to-date basis. This shows that UnitedHealth Group is outperforming its peers so far this year.
Looking more specifically, UNH belongs to the Medical - HMOs industry, a group that includes 12 individual stocks and currently sits at #88 in the Zacks Industry Rank. Stocks in this group have gained about 23.02% so far this year, so UNH is slightly underperforming its industry this group in terms of year-to-date returns.
UNH will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is UnitedHealth Group (UNH - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
UnitedHealth Group is a member of the Medical sector. This group includes 841 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. UNH is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for UNH's full-year earnings has moved 0.79% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that UNH has returned about 22.10% since the start of the calendar year. Meanwhile, the Medical sector has returned an average of 1.12% on a year-to-date basis. This shows that UnitedHealth Group is outperforming its peers so far this year.
Looking more specifically, UNH belongs to the Medical - HMOs industry, a group that includes 12 individual stocks and currently sits at #88 in the Zacks Industry Rank. Stocks in this group have gained about 23.02% so far this year, so UNH is slightly underperforming its industry this group in terms of year-to-date returns.
UNH will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on UNH - FREE